RE:RE:ANSWER OS BELLUS...The alzehimer drug trials of Tramiprosate is what you are referring to is now close to starting Ph 3 at a company called Alzheon. Run by Martin Tolar(a Bellus director) and supported by a team of some of the very best in neurology/ alzheimers.Bellus sold the rights and data set of the Tramiprosate trials to Alzheon for future royalties. Look up Alzheon and see what the data from the previous drug trials have revealed. It is invaluable information for future drug development. Failed drug trials, while painful to all involved, are not the end. If any of you understand the world of drug discovery you will understand this is not easy, it is not fast and it is certainly not cheap.